NCT04952558

Brief Summary

Introduction The incidence of inflammatory bowel disease \[IBD\] is increasing worldwide. Both Crohn's disease \[CD\] and ulcerative colitis \[UC\] are therefore becoming an important public health issue\[1\] The IBD is characterized by chronic intestinal inflammation, which can cause bowel damage and intestinal complications primarily depending on the duration and severity of the inflammation\[2\] The diagnosis of inflammatory bowel diseases (IBD) is often established following considerable delay due to nonspecific and inconsistent symptoms. In previous western studies, the delayed diagnosis was associated with poor outcome in patients with Crohn's disease (CD).\[2\] Timely diagnosis is not only important for the patients themselves but has also become a relevant public health issue due to the rising incidence of IBD worldwide\[3\] Patients and methods Cross sectional observational study will be conducted among 700 patients of Egyptian inflammatory bowel diseased patients for different regions Aim of the study

  1. 1.Estimate time delay for diagnosis of Egyptian inflammatory bowel diseased patients
  2. 2.compare the delay time for diagnosis of Egyptian inflammatory bowel diseased patients globally

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
700

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 7, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

July 7, 2021

Status Verified

June 1, 2021

Enrollment Period

6 months

First QC Date

June 28, 2021

Last Update Submit

June 28, 2021

Conditions

Keywords

Lag timeinflammatory bowel disease

Outcome Measures

Primary Outcomes (2)

  • measure time delay for diagnosis of Egyptian inflammatory bowel diseased patients

    duration in months from the first symptoms appearance till the definite diagnosis

    2 months

  • compare the delay time for diagnosis of Egyptian inflammatory bowel diseased patients globally

    difference in months between global delay and Egyptian delay for diagnosis of inflammatory bowel disease

    4 months

Study Arms (1)

Cross sectional observational study

Cross sectional observational study will be conducted among 700 patients of Egyptian inflammatory bowel diseased patients for different regions Detailed history will be taken from all included patients focus on * age ,sex , special habit ,residence . * education level -socioeconomic status * type of the inflammatory bowel disease * lag time for reaching the proper diagnosis of inflammatory bowel disease which definite as time from the first symptoms presentation to reaching definite diagnosis * symptoms that causing patients seeking medical advice * number of Inflammatory bowel diseased patients referred for first time from surgeons * number of patients have perianal symptoms * number of patients have previous history of appendicectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Cross sectional observational study will be conducted among 700 patients of Egyptian inflammatory bowel diseased patients for different regions

You may qualify if:

  • Egyptian inflammatory bowel diseased patients above the age of 18 years with definite diagnosis based on clinical ,endoscopic ,histological basis

You may not qualify if:

  • Inflammatory bowel diseased Patients below 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bahaa Osman Taha

Asyut, 71515, Egypt

RECRUITING

MeSH Terms

Conditions

Inflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
4 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

June 28, 2021

First Posted

July 7, 2021

Study Start

July 1, 2021

Primary Completion

January 1, 2022

Study Completion

March 1, 2022

Last Updated

July 7, 2021

Record last verified: 2021-06

Locations